JB Chemicals & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	JB Chem & Pharma	Gland Pharma	Glaxosmithkline Phar
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	19.0 .	388.0 .	n/a
Number of ANDA's Approved By USFDA	17.0 .	337.0 .	n/a
Domestic Sales Growth - YoY	10.1 %	n/a	8.9 %
R&D as a % of Total Sales	1.35 %	4.0 %	0.07 %
Financials
5 yr Average ROE	17.95 %	12.02 %	45.03 %
5yr average Equity Multiplier	1.51	1.15	1.87
5yr Average Asset Turnover Ratio	0.76	0.51	0.92
5yr Avg Net Profit Margin	15.74 %	20.79 %	27.88 %
Price to Book	9.6	3.96	18.41
P/E	56.28	39.94	40.28
5yr Avg Cash Conversion Cycle	15.08 Days	69.81 Days	-107.65 Days
Inventory Days	50.96 Days	118.26 Days	47.69 Days
Days Receivable	72.72 Days	99.92 Days	24.45 Days
Days Payable	94.5 Days	107.43 Days	155.09 Days
5yr Average Interest Coverage Ratio	76.53	183.05	556.84
5yr Avg ROCE	20.71 %	16.55 %	48.35 %
5yr Avg Operating Profit Margin	24.61 %	29.26 %	27.99 %
5 yr average Debt to Equity	0.07	0.01	0.0
5yr CAGR Net Profit	12.98 %	-6.87 %	-9.37 %
5yr Average Return on Assets	11.91 %	10.65 %	24.4 %
Shareholdings
Promoter Holding	48.8 %	51.83 %	75.0 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-5.13 %	-6.03 %	0.0
Change in Mutual Fund Holding (3 Yrs)	2.83 %	11.53 %	0.62 %

	JB Chem & Pharma	Gland Pharma	Glaxosmithkline Phar
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 59.64 Formulations 27.81 Contract Manufacturing 10.74 Active Pharmaceutical Ingredient (API) 1.82 Injectables 0 Pharmaceuticals 0 Vaccines 0	Product Wise Break-Up Domestic Formulations 0 Injectables 0 Pharmaceutical 100.0 Contract Manufacturing 0 Active Pharmaceutical Ingredient (API) 0 Vaccines 0 Formulations 0	Product Wise Break-Up Domestic Formulations 0 Injectables 0 Pharmaceutical 76.0 Contract Manufacturing 0 Active Pharmaceutical Ingredient (API) 0 Vaccines 24.0 Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 59.64 Rest of the World 40.36 Russia 0 South Africa 0 USA 0 Core Markets 0 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0	Location Wise Break-Up Canada, Australia & New Zealand 3.37 Rest of the World 0 Canada 0 India 3.84 Russia 0 USA 56.27 Europe 21.88 Australia 0 Core Markets 71.57 South Africa 0	Location Wise Break-Up Canada, Australia & New Zealand 0 Rest of the World 1.36 Canada 0 India 98.64 Russia 0 USA 0 Europe 0 Australia 0 Core Markets 0 South Africa 0
Customer Wise Break-Up	Customer Wise Break-Up THINQ PHARMA-CRO PVT LTD 7.83 Others 92.17	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 95.66 Others 4.34	-	-